ANIKA THERAPEUTICS ($ANIK) posted quarterly earnings results for Q1 2026 on Wednesday, April 29th. The company reported earnings of $0.27 per share, beating estimates of -$0.16 by $0.43. The company also reported revenue of $29,610,000, beating estimates of $28,704,840 by $905,160.
You can see Quiver Quantitative's $ANIK stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ANIKA THERAPEUTICS Hedge Fund Activity
We have seen 74 institutional investors add shares of ANIKA THERAPEUTICS stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TRIGRAN INVESTMENTS, INC. removed 1,452,815 shares (-89.6%) from their portfolio in Q4 2025, for an estimated $13,961,552
- MORGAN STANLEY added 377,489 shares (+95.6%) to their portfolio in Q4 2025, for an estimated $3,627,669
- TWO SIGMA INVESTMENTS, LP added 153,887 shares (+192.5%) to their portfolio in Q4 2025, for an estimated $1,478,854
- D. E. SHAW & CO., INC. added 122,664 shares (+70.0%) to their portfolio in Q4 2025, for an estimated $1,178,801
- DIMENSIONAL FUND ADVISORS LP removed 106,844 shares (-17.8%) from their portfolio in Q4 2025, for an estimated $1,026,770
- TWO SIGMA ADVISERS, LP added 89,600 shares (+242.9%) to their portfolio in Q4 2025, for an estimated $861,056
- BLACKROCK, INC. removed 87,225 shares (-5.0%) from their portfolio in Q4 2025, for an estimated $838,232
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
ANIKA THERAPEUTICS Analyst Ratings
Wall Street analysts have issued reports on $ANIK in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 02/27/2026
To track analyst ratings and price targets for ANIKA THERAPEUTICS, check out Quiver Quantitative's $ANIK forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
